Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging.

Krell-Roesch J, Vassilaki M, Mielke MM, Kremers WK, Lowe VJ, Vemuri P, Machulda MM, Christianson TJ, Syrjanen JA, Stokin GB, Butler LM, Traber M, Jack CR Jr, Knopman DS, Roberts RO, Petersen RC, Geda YE.

Transl Psychiatry. 2019 Mar 28;9(1):123. doi: 10.1038/s41398-019-0456-z.

2.

Prevalence of ideal cardiovascular health in a Central European community: results from the Kardiovize Brno 2030 Project.

Medina-Inojosa JR, Vinciguerra M, Maugeri A, Kunzova S, Sochor O, Movsisyan N, Geda YE, Stokin GB, Lopez-Jimenez F.

Eur J Prev Cardiol. 2019 Mar 6:2047487319834875. doi: 10.1177/2047487319834875. [Epub ahead of print] No abstract available.

PMID:
30841746
3.

Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of Aging.

Krell-Roesch J, Lowe VJ, Neureiter J, Pink A, Roberts RO, Mielke MM, Vemuri P, Stokin GB, Christianson TJ, Jack CR, Knopman DS, Boeve BF, Kremers WK, Petersen RC, Geda YE.

Int Psychogeriatr. 2018 Feb;30(2):245-251. doi: 10.1017/S1041610217002368. Epub 2017 Dec 4.

4.

αSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease.

Pozo Devoto VM, Dimopoulos N, Alloatti M, Pardi MB, Saez TM, Otero MG, Cromberg LE, Marín-Burgin A, Scassa ME, Stokin GB, Schinder AF, Sevlever G, Falzone TL.

Sci Rep. 2017 Jul 11;7(1):5042. doi: 10.1038/s41598-017-05334-9.

5.

Cortical Thickness and Depressive Symptoms in Cognitively Normal Individuals: The Mayo Clinic Study of Aging.

Pink A, Przybelski SA, Krell-Roesch J, Stokin GB, Roberts RO, Mielke MM, Knopman DS, Jack CR, Petersen RC, Geda YE.

J Alzheimers Dis. 2017;58(4):1273-1281. doi: 10.3233/JAD-170041.

6.

YAP regulates cell mechanics by controlling focal adhesion assembly.

Nardone G, Oliver-De La Cruz J, Vrbsky J, Martini C, Pribyl J, Skládal P, Pešl M, Caluori G, Pagliari S, Martino F, Maceckova Z, Hajduch M, Sanz-Garcia A, Pugno NM, Stokin GB, Forte G.

Nat Commun. 2017 May 15;8:15321. doi: 10.1038/ncomms15321.

7.

Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.

Krell-Roesch J, Vemuri P, Pink A, Roberts RO, Stokin GB, Mielke MM, Christianson TJ, Knopman DS, Petersen RC, Kremers WK, Geda YE.

JAMA Neurol. 2017 Mar 1;74(3):332-338. doi: 10.1001/jamaneurol.2016.3822.

8.

Tau Isoforms Imbalance Impairs the Axonal Transport of the Amyloid Precursor Protein in Human Neurons.

Lacovich V, Espindola SL, Alloatti M, Pozo Devoto V, Cromberg LE, Čarná ME, Forte G, Gallo JM, Bruno L, Stokin GB, Avale ME, Falzone TL.

J Neurosci. 2017 Jan 4;37(1):58-69. doi: 10.1523/JNEUROSCI.2305-16.2016.

9.

Timing of Physical Activity, Apolipoprotein E ε4 Genotype, and Risk of Incident Mild Cognitive Impairment.

Krell-Roesch J, Pink A, Roberts RO, Stokin GB, Mielke MM, Spangehl KA, Bartley MM, Knopman DS, Christianson TJ, Petersen RC, Geda YE.

J Am Geriatr Soc. 2016 Dec;64(12):2479-2486. doi: 10.1111/jgs.14402. Epub 2016 Nov 1.

10.

Cortical Thickness and Anxiety Symptoms Among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging.

Pink A, Przybelski SA, Krell-Roesch J, Stokin GB, Roberts RO, Mielke MM, Spangehl KA, Knopman DS, Jack CR Jr, Petersen RC, Geda YE.

J Neuropsychiatry Clin Neurosci. 2017 Winter;29(1):60-66. doi: 10.1176/appi.neuropsych.15100378. Epub 2016 Aug 31.

11.

FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging.

Krell-Roesch J, Ruider H, Lowe VJ, Stokin GB, Pink A, Roberts RO, Mielke MM, Knopman DS, Christianson TJ, Machulda MM, Jack CR, Petersen RC, Geda YE.

J Alzheimers Dis. 2016 Jul 14;53(4):1609-16. doi: 10.3233/JAD-160326.

12.

Mild Neurocognitive Disorder: An Old Wine in a New Bottle.

Stokin GB, Krell-Roesch J, Petersen RC, Geda YE.

Harv Rev Psychiatry. 2015 Sep-Oct;23(5):368-76. doi: 10.1097/HRP.0000000000000084. Review.

13.

APOE ε4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons.

Krell-Roesch J, Woodruff BK, Acosta JI, Locke DE, Hentz JG, Stonnington CM, Stokin GB, Nagle C, Michel BF, Sambuchi N, Caselli RJ, Geda YE.

J Neuropsychiatry Clin Neurosci. 2015 Fall;27(4):322-5. doi: 10.1176/appi.neuropsych.14100268. Epub 2015 Mar 24.

14.

Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based study.

Pink A, Stokin GB, Bartley MM, Roberts RO, Sochor O, Machulda MM, Krell-Roesch J, Knopman DS, Acosta JI, Christianson TJ, Pankratz VS, Mielke MM, Petersen RC, Geda YE.

Neurology. 2015 Mar 3;84(9):935-43. doi: 10.1212/WNL.0000000000001307. Epub 2015 Feb 4.

15.

Neuropathologic features of anti-dipeptidyl-peptidase-like protein-6 antibody encephalitis.

Stokin GB, Popović M, Gelpi E, Kogoj A, Dalmau J, Graus F.

Neurology. 2015 Jan 27;84(4):430-2. doi: 10.1212/WNL.0000000000001183. Epub 2014 Dec 17. No abstract available.

16.

Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.

Mellone M, Kestoras D, Andrews MR, Dassie E, Crowther RA, Stokin GB, Tinsley J, Horne G, Goedert M, Tolkovsky AM, Spillantini MG.

J Neurosci. 2013 Nov 13;33(46):18175-89. doi: 10.1523/JNEUROSCI.4933-12.2013.

17.

Imaging amyloid precursor protein in vivo: an axonal transport assay.

Falzone TL, Stokin GB.

Methods Mol Biol. 2012;846:295-303. doi: 10.1007/978-1-61779-536-7_25.

PMID:
22367820
18.

Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P.

Brain. 2009 Oct;132(Pt 10):2659-68. doi: 10.1093/brain/awp191. Epub 2009 Sep 22. Erratum in: Brain. 2012 Apr;135(Pt 4):1335.

19.

Examination of potential mechanisms of amyloid-induced defects in neuronal transport.

Shah SB, Nolan R, Davis E, Stokin GB, Niesman I, Canto I, Glabe C, Goldstein LS.

Neurobiol Dis. 2009 Oct;36(1):11-25. doi: 10.1016/j.nbd.2009.05.016. Epub 2009 Jun 1.

PMID:
19497367
20.

Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects.

Falzone TL, Stokin GB, Lillo C, Rodrigues EM, Westerman EL, Williams DS, Goldstein LS.

J Neurosci. 2009 May 6;29(18):5758-67. doi: 10.1523/JNEUROSCI.0780-09.2009.

21.

Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides.

Stokin GB, Almenar-Queralt A, Gunawardena S, Rodrigues EM, Falzone T, Kim J, Lillo C, Mount SL, Roberts EA, McGowan E, Williams DS, Goldstein LS.

Hum Mol Genet. 2008 Nov 15;17(22):3474-86. doi: 10.1093/hmg/ddn240. Epub 2008 Aug 11.

22.

Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.

Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, Xia W, Villar A, Campbell WA, Kulnane LS, Nixon RA, Lamb BT, Epstein CJ, Stokin GB, Goldstein LS, Mobley WC.

Neuron. 2006 Jul 6;51(1):29-42.

23.

Axonal transport and Alzheimer's disease.

Stokin GB, Goldstein LS.

Annu Rev Biochem. 2006;75:607-27. Review.

PMID:
16756504
24.

Linking molecular motors to Alzheimer's disease.

Stokin GB, Goldstein LS.

J Physiol Paris. 2006 Mar-May;99(2-3):193-200. Epub 2006 Feb 3. Review.

PMID:
16459060
25.

Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease.

Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS.

Science. 2005 Feb 25;307(5713):1282-8.

26.
28.

Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42.

Perez RG, Soriano S, Hayes JD, Ostaszewski B, Xia W, Selkoe DJ, Chen X, Stokin GB, Koo EH.

J Biol Chem. 1999 Jul 2;274(27):18851-6.

Supplemental Content

Loading ...
Support Center